Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06787690 · ClinicalTrials.gov registry record · NA
Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds
A NA study of Surgical Wound and Burn, sponsored by Avita Medical.
- Active
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 18
- Study locations
NCT06787690: Active NA study of Surgical Wound and Burn, sponsored by Avita Medical.
NCT06787690 is a NA study of Surgical Wound and Burn that is active but no longer recruiting, run by Avita Medical. The registered enrollment target is 41 participants, below the 93-participant average among 17 other Surgical Wound trials with a reported enrollment target (56% lower). The trial reports 18 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06787690, a NA study of Surgical Wound and Burn, is active but no longer recruiting, sponsored by Avita Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 18
- Study locations
Study Summary
The goal of this study is to look at clinical outcomes when Cohealyx Collagen Matrix is used to treat full thickness wounds after surgical excision in patients that require a skin graft to heal their wounds. The main question it aims to answer is how long does it take for Cohealyx to support definitive closure.
Primary Outcome
Defined as the number of days from placement of Cohealyx until placement of an autologous split-thickness skin graft
Conditions Studied
Interventions
- DEVICE Cohealyx
Study Locations (18)
Arizona
- Valleywise Health - Phoenix
- University of Arizona - Tucson
Ohio
- Akron Children's Hospital - Akron
- Ohio State University - Columbus
Texas
- JPS Health Network - Fort Worth
- Texas Tech University - Lubbock
Alabama
- University of South Alabama - Mobile
District of Columbia
- Medstar Washington Hospital Center - Washington D.C.
Iowa
- Univ of Iowa - Iowa City
Kansas
- The University of Kansas Health - Kansas City
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2026-08 |
| Phase | NA |
What the registry record for NCT06787690 still lists
NCT06787690 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 93-participant average among 17 other Surgical Wound trials with a reported enrollment target (56% lower).
The record links to 4 conditions, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Cohealyx is the first listed.
NCT06787690 lists 18 locations in 15 states (Arizona, Ohio, Texas).
Frequently Asked Questions
What is clinical trial NCT06787690 about?
NCT06787690 is a clinical study titled "Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds". The goal of this study is to look at clinical outcomes when Cohealyx Collagen Matrix is used to treat full thickness wounds after surgical excision in patients that require a skin graft to heal their wounds. The main question it aims to answer is how long does it take for Cohealyx to support definit...
What is the current status of trial NCT06787690?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 41 participants. The study started on 2025-05-15. Estimated completion is 2026-08.
What conditions does trial NCT06787690 study?
This clinical trial studies the following conditions: Surgical Wound, Burn, Trauma Wound, Full Thickness Wounds.
What interventions are being tested in trial NCT06787690?
The interventions under investigation include: Cohealyx (DEVICE).
Who is sponsoring clinical trial NCT06787690?
This trial is sponsored by Avita Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06787690 being conducted?
This trial has 18 study locations across Alabama, Arizona, District of Columbia, Iowa, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06787690's enrollment target sits among peer trials
41 11th of 17 higher than 7 of 17 other Surgical Wound trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
RECRUITING · NA
-
Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
ACTIVE NOT RECRUITING · NA
-
Suture Closure Trial
ACTIVE NOT RECRUITING · NA
-
Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds
ACTIVE NOT RECRUITING · NA
-
RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)
COMPLETED · NA
-
Continuous Diffusion of Oxygen Treatment for Incision Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI